Organigram Global (OGI) EBIT (2018 - 2021)
Historic EBIT for Organigram Global (OGI) over the last 4 years, with Q2 2021 value amounting to -$12.2 million.
- Organigram Global's EBIT rose 8770.0% to -$12.2 million in Q2 2021 from the same period last year, while for May 2021 it was -$115.6 million, marking a year-over-year decrease of 850.27%. This contributed to the annual value of -$10.9 million for FY2025, which is 5715.19% up from last year.
- Organigram Global's EBIT amounted to -$12.2 million in Q2 2021, which was up 8770.0% from -$28213.0 recorded in Q1 2021.
- Organigram Global's EBIT's 5-year high stood at $46.2 million during Q4 2018, with a 5-year trough of -$99.3 million in Q2 2020.
- Over the past 4 years, Organigram Global's median EBIT value was -$1.8 million (recorded in 2019), while the average stood at -$4.5 million.
- Its EBIT has fluctuated over the past 5 years, first tumbled by 77977.5% in 2020, then surged by 8770.0% in 2021.
- Organigram Global's EBIT (Quarter) stood at $46.2 million in 2018, then plummeted by 99.67% to $154000.0 in 2019, then tumbled by 64586.36% to -$99.3 million in 2020, then soared by 87.7% to -$12.2 million in 2021.
- Its EBIT stands at -$12.2 million for Q2 2021, versus -$28213.0 for Q1 2021 and -$99.3 million for Q2 2020.